TANDEM DIABETES CARE INC (TNDM) Stock News
NASDAQ:TNDM - Nasdaq - US8753722037 - Common Stock - Currency: USD
TNDM Latest News, Press Relases and Analysis
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up
Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -11.67% and 6.44%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: NUWE
Reasons to Hold TNDM Stock in Your Portfolio for Now
A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
Tandem Diabetes Care Announces First Quarter 2025 Financial Results
M&A is slowing in US but accelerating worldwide during new Trump era
US M&A is having its slowest start to a year since 2023, while deal volume outside the US soars to its best result since 2022.
What to Expect From These 3 MedTech Stocks This Earnings Season?
Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.
Penumbra (PEN) Q1 Earnings and Revenues Top Estimates
Penumbra (PEN) delivered earnings and revenue surprises of 25.76% and 2.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PEN
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
Why Empire Petroleum Corporation (EP) Stock is Gaining This Week
We recently compiled a list of the Energy Stocks that are Gaining This Week. In this article, we are going to take a look at where Empire Petroleum Corporation (NYSE:EP) stands against the other energy stocks. The energy industry has found itself right in the crosshairs of President Trump’s tariff war, sliding more than 8% over the […]
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. Let's consider two examples: Teladoc Health (NYSE: TDOC) and Tandem Diabetes Care (NASDAQ: TNDM). Teladoc Health, a telemedicine specialist, might not feel a substantial direct impact from Trump's tariffs.
Mentions: TDOC
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
Mentions: TDOC
When It’s Safe — or Not — To Share Your Banking Info
Have you ever been asked for your checking account number or bank's routing number? Maybe it was for a wire transfer or to set up direct deposit. Whatever the case, it's generally okay to share your...
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
Is Salesforce, Inc. (CRM) The Mega Cap Stock Gaining Bullish Momentum This Week?
We recently published a list of 10 Mega Cap Stocks Gaining Bullish Momentum This Week. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against other mega cap stocks gaining bullish momentum this week. The S&P 500 index started the week with a bang after staying under pressure […]
Is Oracle Corporation (ORCL) The Mega Cap Stock Gaining Bullish Momentum This Week?
We recently published a list of 10 Mega Cap Stocks Gaining Bullish Momentum This Week. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against other mega cap stocks gaining bullish momentum this week. The S&P 500 index started the week with a bang after staying under pressure […]
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's Shares
Shares hit their lowest point since January 2024 after the stock market opened Thursday.